Abstract
Pharmaceutical is the core of Bangladesh’s Healthcare sector with an annual average growth rate consistently in the double digits. The real growth of local pharmaceutical industries started after the “Drug Control Ordinance-1982’'. This research is based on Primary and secondary data. Presently, the industry meets 97% of local demand and exports to more than 80 countries. Generic drugs in Bangladesh estimates to reach BDT 30,300 core by 2024. A local industry supporting drug policy and effective regulatory framework, along with trade related aspects of intellectual property rights relaxations are the key reasons for success of the industry. Prime Minister Sheikh Hasina has named pharmaceuticals the Product of the Year for 2018. Prospect of the sector depends largely on the interactions among the proprietors, regulatory bodies and the government, whether they can meet up the requisites to continue growth of the sector while facing the challenge.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Pharmaceutical Investigation
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
